Since CD200 can be expressed by both host cells and breast tumor cells in vivo, we hypothesized that the location of expression of CD200 and/or CD200R contributes importantly the mechanism(s) triggered which might lead to host tumor resistance, and help explain some of our earlier findings cited above. This evidence concerns the gene CD200 and breast neoplasm.